vs

Side-by-side financial comparison of DYNEX CAPITAL INC (DX) and Evolus, Inc. (EOLS). Click either name above to swap in a different company.

Evolus, Inc. is the larger business by last-quarter revenue ($73.1M vs $43.5M, roughly 1.7× DYNEX CAPITAL INC). On growth, DYNEX CAPITAL INC posted the faster year-over-year revenue change (531.3% vs 6.7%). Over the past eight quarters, DYNEX CAPITAL INC's revenue compounded faster (75.8% CAGR vs 4.6%).

Dynex Capital Inc. is a publicly traded real estate investment trust headquartered in the United States. It specializes in investing in and managing a diversified portfolio of mortgage-backed securities, residential and commercial mortgage loans, and other mortgage-related assets. It delivers consistent returns to shareholders via regular dividends and long-term capital growth.

Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.

DX vs EOLS — Head-to-Head

Bigger by revenue
EOLS
EOLS
1.7× larger
EOLS
$73.1M
$43.5M
DX
Growing faster (revenue YoY)
DX
DX
+524.6% gap
DX
531.3%
6.7%
EOLS
Faster 2-yr revenue CAGR
DX
DX
Annualised
DX
75.8%
4.6%
EOLS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
DX
DX
EOLS
EOLS
Revenue
$43.5M
$73.1M
Net Profit
$-10.7M
Gross Margin
66.9%
Operating Margin
23.8%
Net Margin
-14.6%
Revenue YoY
531.3%
6.7%
Net Profit YoY
EPS (diluted)
$1.59
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DX
DX
EOLS
EOLS
Q1 26
$73.1M
Q4 25
$43.5M
$90.3M
Q3 25
$30.6M
$69.0M
Q2 25
$23.1M
$69.4M
Q1 25
$17.1M
$68.5M
Q4 24
$78.9M
Q3 24
$61.1M
Q2 24
$66.9M
Net Profit
DX
DX
EOLS
EOLS
Q1 26
$-10.7M
Q4 25
$130.0K
Q3 25
$150.4M
$-15.7M
Q2 25
$-13.6M
$-17.1M
Q1 25
$-3.1M
$-18.9M
Q4 24
$-6.8M
Q3 24
$-19.2M
Q2 24
$-11.3M
Gross Margin
DX
DX
EOLS
EOLS
Q1 26
66.9%
Q4 25
65.7%
Q3 25
66.5%
Q2 25
65.3%
Q1 25
68.1%
Q4 24
66.7%
Q3 24
68.9%
Q2 24
70.3%
Operating Margin
DX
DX
EOLS
EOLS
Q1 26
23.8%
Q4 25
4.7%
Q3 25
-16.7%
Q2 25
-14.7%
Q1 25
-22.1%
Q4 24
-2.9%
Q3 24
-25.3%
Q2 24
-11.5%
Net Margin
DX
DX
EOLS
EOLS
Q1 26
-14.6%
Q4 25
0.1%
Q3 25
491.3%
-22.8%
Q2 25
-58.8%
-24.7%
Q1 25
-18.0%
-27.6%
Q4 24
-8.6%
Q3 24
-31.4%
Q2 24
-17.0%
EPS (diluted)
DX
DX
EOLS
EOLS
Q1 26
$-0.16
Q4 25
$1.59
$0.01
Q3 25
$1.08
$-0.24
Q2 25
$-0.14
$-0.27
Q1 25
$-0.06
$-0.30
Q4 24
$-0.11
Q3 24
$-0.30
Q2 24
$-0.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DX
DX
EOLS
EOLS
Cash + ST InvestmentsLiquidity on hand
$531.0M
$49.8M
Total DebtLower is stronger
$156.4M
Stockholders' EquityBook value
$2.5B
Total Assets
$17.3B
$220.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DX
DX
EOLS
EOLS
Q1 26
$49.8M
Q4 25
$531.0M
$53.8M
Q3 25
$491.0M
$43.5M
Q2 25
$387.5M
$61.7M
Q1 25
$327.4M
$67.9M
Q4 24
$87.0M
Q3 24
$85.0M
Q2 24
$93.7M
Total Debt
DX
DX
EOLS
EOLS
Q1 26
$156.4M
Q4 25
$146.1M
Q3 25
Q2 25
Q1 25
$121.8M
Q4 24
$121.5M
Q3 24
$121.2M
Q2 24
$120.9M
Stockholders' Equity
DX
DX
EOLS
EOLS
Q1 26
Q4 25
$2.5B
$-23.1M
Q3 25
$2.0B
$-28.8M
Q2 25
$1.6B
$-18.7M
Q1 25
$1.4B
$-6.6M
Q4 24
$5.5M
Q3 24
$5.9M
Q2 24
$19.3M
Total Assets
DX
DX
EOLS
EOLS
Q1 26
$220.6M
Q4 25
$17.3B
$225.9M
Q3 25
$14.2B
$219.0M
Q2 25
$11.3B
$228.8M
Q1 25
$9.0B
$213.4M
Q4 24
$232.6M
Q3 24
$229.6M
Q2 24
$233.8M
Debt / Equity
DX
DX
EOLS
EOLS
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
22.00×
Q3 24
20.58×
Q2 24
6.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DX
DX
EOLS
EOLS
Operating Cash FlowLast quarter
$120.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DX
DX
EOLS
EOLS
Q1 26
Q4 25
$120.8M
$12.8M
Q3 25
$68.3M
$-14.7M
Q2 25
$31.9M
$-24.8M
Q1 25
$6.4M
$-15.6M
Q4 24
$4.8M
Q3 24
$-5.7M
Q2 24
$-6.5M
Free Cash Flow
DX
DX
EOLS
EOLS
Q1 26
Q4 25
$11.3M
Q3 25
$-15.6M
Q2 25
$-25.5M
Q1 25
$-16.0M
Q4 24
$4.4M
Q3 24
$-6.0M
Q2 24
$-6.9M
FCF Margin
DX
DX
EOLS
EOLS
Q1 26
Q4 25
12.6%
Q3 25
-22.7%
Q2 25
-36.7%
Q1 25
-23.3%
Q4 24
5.5%
Q3 24
-9.9%
Q2 24
-10.4%
Capex Intensity
DX
DX
EOLS
EOLS
Q1 26
Q4 25
1.6%
Q3 25
1.4%
Q2 25
1.0%
Q1 25
0.5%
Q4 24
0.6%
Q3 24
0.5%
Q2 24
0.7%
Cash Conversion
DX
DX
EOLS
EOLS
Q1 26
Q4 25
98.67×
Q3 25
0.45×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DX
DX

Segment breakdown not available.

EOLS
EOLS

Product revenue, net$72.7M99%
Service revenue$390.0K1%

Related Comparisons